Related Experiment Videos
Multiple sclerosis and spasticity.
Jodie K Haselkorn1, Sharon Loomis
1VA Puget Sound Health Care System, Seattle, WA, USA. jodie.haselkorn@med.va.gov
Summary
Managing spasticity in multiple sclerosis (MS) is complex due to central nervous system lesions. Optimal individualized treatment requires skilled clinical assessment and frequent monitoring, as current strategies are not ideal.
Area of Science:
- Neurology
- Rehabilitation Medicine
Background:
- Spasticity is a frequent and disabling symptom in multiple sclerosis (MS).
- It leads to significant medical complications and functional decline.
- MS-related brain and spinal cord lesions complicate spasticity management.
Purpose of the Study:
- To review current treatment strategies for spasticity in MS.
- To highlight the challenges in managing MS-related spasticity.
- To emphasize the need for individualized and skilled clinical approaches.
Main Methods:
- Review of existing literature on MS spasticity management.
- Discussion of various treatment modalities including rehabilitation, pharmacotherapy, and surgical options.
- Analysis of challenges posed by secondary impairments and polypharmacy in MS patients.
Main Results:
- Rehabilitation is a cornerstone of MS spasticity management.
- Current treatment strategies are suboptimal, with limited head-to-head comparative studies.
- Pharmaceutical management is complicated by MS-specific factors and polypharmacy.
Conclusions:
- Effective spasticity management is crucial for the well-being and functional status of individuals with MS.
- Optimal treatment requires individualized plans, skilled clinical judgment, and frequent monitoring.
- Referral to specialized MS centers is recommended for refractory cases.